scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0306-4522(98)00488-6 |
P698 | PubMed publication ID | 10077333 |
P2093 | author name string | P Chen | |
T L Yaksh | |||
X Y Hua | |||
M Marsala | |||
P2860 | cites work | Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice | Q28334553 |
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
Characterization of inducible cyclooxygenase in rat brain | Q33593129 | ||
Molecular characterization of a functional cDNA encoding the rat substance P receptor | Q33891305 | ||
Effect of bradykinin and prostaglandins on the release of calcitonin gene‐related peptide‐like immunoreactivity from the rat spinal cord in vitro | Q35870977 | ||
A cure for wind up: NMDA receptor antagonists as potential analgesics | Q37890801 | ||
Activation of protein kinase C promotes glutamate-mediated transmission at the neuromuscular junction of the mealworm | Q38596828 | ||
Slow excitatory transmission in rat dorsal horn: possible mediation by peptides | Q39341067 | ||
Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters | Q39370851 | ||
Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro | Q39402486 | ||
The physiology of excitatory amino acids in the vertebrate central nervous system | Q39462515 | ||
Excitatory Amino Acid Transmitters | Q40084320 | ||
Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons | Q40349945 | ||
Temperature dependency of basal and evoked release of amino acids and calcitonin gene-related peptide from rat dorsal spinal cord | Q40650540 | ||
Nitric oxide (NO) and nociceptive processing in the spinal cord | Q40887811 | ||
Peptides and the primary afferent nociceptor | Q40911083 | ||
The origin, distribution and synaptic relationships of substance P axons in rat spinal cord | Q40993620 | ||
Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation | Q41346813 | ||
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. | Q41662482 | ||
Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses | Q42200367 | ||
Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons | Q42454277 | ||
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain | Q43664339 | ||
Effect of substance P in cat dorsal horn neurones activated by noxious stimuli | Q43689036 | ||
Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors | Q44225100 | ||
Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid | Q44335232 | ||
Substance P and Spinal Neurones | Q44488291 | ||
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. | Q44603003 | ||
Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependent | Q44608700 | ||
Antinociceptive effect of taurine and its inhibition by naxolone | Q44911020 | ||
Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. | Q45989015 | ||
Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction | Q46008800 | ||
Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test | Q46135927 | ||
Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. | Q46510308 | ||
Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 release | Q46601601 | ||
Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity | Q46914865 | ||
Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamate | Q48258041 | ||
Increase in substance P in the dorsal horn during a chemogenic nociceptive stimulus | Q48470698 | ||
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation | Q48493712 | ||
A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? | Q48589494 | ||
Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat | Q48607741 | ||
Neurotransmitter candidates of somatosensory primary afferent fibres | Q48712380 | ||
Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord | Q48826416 | ||
Characteristics of substance P-evoked release of amino acids from neonatal rat spinal cord. | Q51596606 | ||
Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists. | Q51650419 | ||
Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. | Q52198922 | ||
Excitatory amino acid-mediated components of synaptically evoked input from dorsal roots to deep dorsal horn neurons in the rat spinal cord slice. | Q54340704 | ||
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo | Q59061346 | ||
The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord | Q60679697 | ||
Antinociceptive effects of intrathecal taurine and calcium in the mouse | Q67536791 | ||
Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykinins | Q67542207 | ||
Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice | Q67661642 | ||
Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord | Q67675192 | ||
Characterization of the hyperalgesic effect induced by intrathecal injection of substance P | Q68938608 | ||
Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ | Q69084852 | ||
Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test | Q69528189 | ||
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation | Q71256145 | ||
Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study | Q71852011 | ||
Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade | Q71924140 | ||
Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing | Q71940261 | ||
Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint | Q71978632 | ||
Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors | Q72071706 | ||
Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation | Q72259523 | ||
Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin | Q72413267 | ||
Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter | Q72633469 | ||
Substance P reduces tail-flick latency: implications for chronic pain syndromes | Q72685061 | ||
Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins | Q72844995 | ||
Spontaneous and evoked release of prostaglandins from frog spinal cord | Q72883308 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostaglandin E2 | Q416554 |
P1104 | number of pages | 10 | |
P304 | page(s) | 525-534 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids | |
P478 | volume | 89 |
Q41780863 | Acetaminophen prevents hyperalgesia in central pain cascade |
Q34515061 | Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. |
Q36449385 | Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons |
Q40735769 | Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats |
Q42126244 | Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists |
Q42792495 | Changes in Tissue Substance P Levels in Patients With Carpal Tunnel Syndrome |
Q47596315 | Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain |
Q40563340 | Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair. |
Q43298954 | Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain |
Q33784210 | Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-rat |
Q35028598 | In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin |
Q44597452 | Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons |
Q46973494 | Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia |
Q37900692 | Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states |
Q52290421 | Managing chronic-pain patients in the new millennium: clinical basis and regulatory viewpoint from Texas, U.S.A. |
Q34199035 | Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord |
Q44000335 | Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury |
Q34183893 | Role of prostaglandins in spinal transmission of the exercise pressor reflex in decerebrated rats |
Q40771606 | Role of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression |
Q43263235 | Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal |
Q43792449 | Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. |
Q33216935 | Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception |
Q48617592 | Substance P initiates NFAT-dependent gene expression in spinal neurons |
Q43697187 | The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. |
Q34746394 | The neuropharmacology of centrally-acting analgesic medications in fibromyalgia |
Q24677387 | The role of spinal neuropeptides and prostaglandins in opioid physical dependence |
Q33679499 | The spinal biology in humans and animals of pain states generated by persistent small afferent input |
Q35656935 | Up-Regulation of the Biosynthesis and Release of Substance P through Wnt/β-Catenin Signaling Pathway in Rat Dorsal Root Ganglion Cells |